New drug for the reduction of abdominal fat deposits in patients receiving antiviral therapy for HIV infection may also reduce fatty liver disease incidence in such patients, finds new study. In a paper that will appear in the July 23/28 issue of iJAMA/i - a theme issue on HIV/AIDS receiving early online release to coincide with the International AIDS Conference - Massachusetts General Hospital (MGH) investigators report that daily injections of tesamorelin significantly ...Sunday 20 July 2014
New Drug That Reduces Abdominal Fat in HIV Patients also may Reduce Fat in Liver
New drug for the reduction of abdominal fat deposits in patients receiving antiviral therapy for HIV infection may also reduce fatty liver disease incidence in such patients, finds new study. In a paper that will appear in the July 23/28 issue of iJAMA/i - a theme issue on HIV/AIDS receiving early online release to coincide with the International AIDS Conference - Massachusetts General Hospital (MGH) investigators report that daily injections of tesamorelin significantly ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment